Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.41
Dec. 10, 2025 15:59:59- Change 0.0282 (7.48408%)
- Volume 1,916,936
- Today's Open 0.36
- Previous Close 0.3768
- Today's High 0.415
- Today's Low 0.36
- 52 Week High 4.3
- 52 Week Low 0.281